Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ansys Key Long-Term Metrics Suspended Amid Pending Synopsys Transaction; Double-Digit ACV Growth With 2022-2024 CAGR Of 12.3% At Actual Rates, 13% At 2022 Rates; Unlevered Operating Cash Flows Growth Of 13.5% CAGR; FY24 Unlevered Cash Flows At $834.6M, Totaling $2.2B From 2022-2024

Author: Benzinga Newsdesk | February 19, 2025 05:32pm

/ Key Long-Term Metrics

The Company's long-term outlook covering the years 2022 through 2025 provided at the 2022 Investor Update has been suspended given the pending transaction with Synopsys. Below is a summary of key metrics covering the years 2022 through 2024.

  • Consistent double-digit ACV growth with a 2022 through 2024 CAGR of 12.3% at actual exchange rates and 13.0% at 2022 exchange rates.
  • Unlevered operating cash flows grew faster than ACV with a 2022 through 2024 CAGR of 13.5%.
  • With FY 2024 unlevered operating cash flows of $834.6 million, cumulative 3-year unlevered operating cash flows (FY 2022 to 2024) are $2.2 billion.
  • Note: 2024 unlevered operating cash flows includes $28.2 million of cash outflows primarily associated with the pending transaction with Synopsys.

Posted In: ANSS SNPS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist